News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
367,371 Results
Type
Article (14687)
Company Profile (115)
Press Release (352569)
Section
Business (113670)
Career Advice (458)
Deals (18740)
Drug Delivery (28)
Drug Development (31527)
Employer Resources (50)
FDA (9036)
Job Trends (7795)
News (174675)
Policy (12588)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1343)
Allergies (36)
Alliances (34917)
ALS (22)
Alzheimer's disease (493)
Antibody-drug conjugate (ADC) (54)
Approvals (9045)
Artificial intelligence (217)
Autoimmune disease (1)
Automation (11)
Bankruptcy (135)
Best Places to Work (6629)
BIOSECURE Act (6)
Biosimilars (11)
Biotechnology (87)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (105)
Cancer (886)
Cardiovascular disease (57)
Career advice (408)
Career pathing (8)
CAR-T (91)
Cell therapy (245)
Cervical cancer (7)
Clinical research (24689)
Collaboration (538)
Compensation (98)
Complete response letters (3)
COVID-19 (1150)
CRISPR (34)
C-suite (117)
Cystic fibrosis (47)
Data (835)
Decentralized trials (1)
Denatured (18)
Depression (14)
Diabetes (84)
Diagnostics (4897)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (69)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (16)
Earnings (38933)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51575)
Executive appointments (347)
FDA (9563)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (422)
Gene editing (78)
Generative AI (23)
Gene therapy (157)
GLP-1 (215)
Government (1256)
Grass and pollen (1)
Guidances (23)
Healthcare (10052)
Huntington's disease (5)
IgA nephropathy (8)
Immunology and inflammation (24)
Indications (9)
Infectious disease (1218)
Inflammatory bowel disease (57)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (47)
Interviews (51)
IPO (8050)
IRA (8)
Job creations (1452)
Job search strategy (364)
Kidney cancer (3)
Labor market (9)
Layoffs (115)
Leadership (3)
Legal (2601)
Liver cancer (34)
Lung cancer (113)
Lymphoma (54)
Machine learning (2)
Management (17)
Manufacturing (159)
MASH (14)
Medical device (11623)
Medtech (11628)
Mergers & acquisitions (10983)
Metabolic disorders (188)
Multiple sclerosis (23)
NASH (3)
Neurodegenerative disease (23)
Neuropsychiatric disorders (2)
Neuroscience (662)
NextGen: Class of 2025 (3590)
Non-profit (1545)
Northern California (976)
Now hiring (8)
Obesity (83)
Opinion (75)
Ovarian cancer (32)
Pain (48)
Pancreatic cancer (35)
Parkinson's disease (59)
Partnered (9)
Patents (117)
Patient recruitment (48)
Peanut (25)
People (32903)
Pharmaceutical (16)
Phase I (9059)
Phase II (11117)
Phase III (7269)
Pipeline (395)
Podcasts (36)
Policy (26)
Postmarket research (532)
Preclinical (4064)
Press Release (66)
Prostate cancer (37)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (128)
Real estate (3386)
Recruiting (20)
Regulatory (9428)
Reports (18)
Research institute (1279)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (1)
RSV (20)
Schizophrenia (11)
Series A (78)
Series B (46)
Service/supplier (7)
Sickle cell disease (16)
Southern California (1058)
Special edition (1)
Sponsored (13)
Startups (2511)
State (2)
Stomach cancer (1)
Supply chain (21)
The Weekly (17)
United States (10327)
Vaccines (299)
Venture capitalists (18)
Webinars (7)
Weight loss (34)
Women's health (16)
Worklife (2)
Date
Today (76)
Last 7 days (301)
Last 30 days (1523)
Last 365 days (18107)
2025 (3443)
2024 (18868)
2023 (22264)
2022 (30992)
2021 (32718)
2020 (30805)
2019 (26057)
2018 (19668)
2017 (19110)
2016 (17983)
2015 (20801)
2014 (15389)
2013 (12924)
2012 (14042)
2011 (14308)
2010 (12998)
Location
Africa (337)
Alabama (36)
Alaska (6)
Arizona (112)
Arkansas (9)
Asia (24101)
Australia (4192)
California (2556)
Canada (957)
China (204)
Colorado (152)
Connecticut (128)
Delaware (35)
Europe (49347)
Florida (429)
Georgia (123)
Idaho (33)
Illinois (252)
India (10)
Indiana (150)
Iowa (4)
Japan (92)
Kansas (79)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (425)
Massachusetts (1793)
Michigan (176)
Minnesota (232)
Mississippi (2)
Missouri (54)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (65)
New Jersey (801)
New Mexico (16)
New York (756)
North Carolina (492)
North Dakota (7)
Northern California (976)
Ohio (96)
Oklahoma (10)
Oregon (19)
Pennsylvania (520)
Puerto Rico (5)
Rhode Island (18)
South America (510)
South Carolina (14)
South Dakota (1)
Southern California (1058)
Tennessee (56)
Texas (407)
Utah (94)
Virginia (54)
Washington D.C. (10)
Washington State (299)
West Virginia (3)
Wisconsin (33)
367,371 Results for "camber spine technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
February 21, 2025
·
4 min read
Press Releases
Expanding Innovations to Showcase Cutting-Edge Expandable Cage Technology at Spine Summit 2025
February 14, 2025
·
2 min read
BioMidwest
Strenge Spine Center Launches Cutting-Edge Spine Care Solutions
Strenge Spine Center, a pioneering provider of advanced spine care, is proud to announce the launch of its state-of-the-art technologies and innovative treatment options, including the EOSedge system.
June 25, 2024
·
3 min read
Press Releases
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
March 12, 2025
·
3 min read
Press Releases
Spine BioPharma, Inc. to Present at the Canaccord Genuity 2025 Musculoskeletal Conference
March 4, 2025
·
1 min read
Press Releases
Precision Spine® Promotes Christopher A. DeNicola to President and CEO
January 27, 2025
·
2 min read
Pharm Country
Camber Spine’s SPIRA-P and SPIRA-T Devices Enter Full National Launch Mode
Camber Spine, a leading innovator in spine and medical technologies has announced that it is entering into the next phase of the complete national launch of the SPIRA-P Posterior Lumbar Spacer and has recently commercialized its Spira-T Oblique Posterior Lumbar Spacer.
June 1, 2022
·
2 min read
Pharm Country
Camber Spine to Roll Out Education Initiatives and Expand Product Portfolio in 2022
Camber Spine, a leading innovator in spine and medical technologies, has announced a robust calendar of clinical education and product portfolio expansions in 2022.
February 22, 2022
·
2 min read
Biotech Beach
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
Aurora Spine Corporation today announced the issuance of its second United States Patent No: 11,850,162 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology.
February 5, 2024
·
4 min read
Press Releases
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion
March 10, 2025
·
4 min read
1 of 36,738
Next
